Market Overview

Benzinga's Top Pre-Market Gainers

Related KYTH
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA
Benzinga's Top Downgrades
Zeltiq Hits New High After Raising Guidance Again (Investor's Business Daily)
Related BCRX
6 Movers To Keep An Eye On Next Week
FedBizOpps Reporting Biocryst Received $12,133,606 For BCX4430 NDA Enabling CMC and Non-Clinical Toxicology Studies

Kythera Biopharmaceuticals (NASDAQ: KYTH) shares jumped 28.69% to $43.15 in pre-market trading after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.

Huntsman (NYSE: HUN) surged 8.05% to $20.68 in the pre-market session after the company announced its plans to buy Rockwood Holdings' (NYSE: ROC) Performance Additives and Titanium Dioxide businesses for $1.1 billion in cash.

BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

Discover Financial Services (NYSE: DFS) soared 4.92% to $54.43 in the pre-market trading. Discover Financial's PEG ratio is 1.26.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (BCRX + DFS)

Get Benzinga's Newsletters